Metabolic and incretin analogs
Incretin analogs act at the receptors regulating insulin secretion, gastric emptying and appetite signalling. The compounds grouped here are single peptides engineered to bind more than one of those receptors at once, which is the property their published trial programmes were built to measure and the reason they are studied as a class rather than individually.
2 compounds in this category
10mg · lyophilized
Triple agonist at the GLP-1, GIP and glucagon receptors. Studied in Phase 2 obesity trials.
Investigational triple agonist of GLP-1, GIP and glucagon receptors under research for metabolic regulation.
Per vial
10mg · lyophilized
Dual GIP and GLP-1 receptor agonist with an extensive published trial record.
Investigational dual agonist of GLP-1 and GIP receptors under research for incretin-mediated metabolic regulation.
Per vial
Deeper reading
Compound background, published research and Philippine sourcing context sit on our partner content site. The store stays a store.
Compound library